Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Shanghai Haohai Biological Technology Co., Ltd. Class H ( (HK:6826) ) has provided an update.
Shanghai Haohai Biological Technology Co., Ltd. has announced key changes in its board and management structure. Dr. Hou Yongtai has been re-elected as Chairman, and Mr. Wu Jianying continues as General Manager, with Ms. Tian Min re-elected as Secretary to the Board and Securities Affairs Representative. These appointments, effective immediately, are part of the company’s strategic efforts to strengthen its governance and operational leadership.
More about Shanghai Haohai Biological Technology Co., Ltd. Class H
Shanghai Haohai Biological Technology Co., Ltd. is a company incorporated in the People’s Republic of China, operating in the biotechnology sector. It focuses on producing biological products and technologies, with a market focus that includes various medical and healthcare applications.
Average Trading Volume: 698,022
Technical Sentiment Signal: Sell
Current Market Cap: HK$11.93B
Find detailed analytics on 6826 stock on TipRanks’ Stock Analysis page.